Home Forums Marketplace Table of Contents Events Member List Site Map Register Mark Forums Read



Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.


BioCis Pharma Starts Phase IIa Trial In Psoriasis

Reply
Submit Thread >  Submit to Digg Submit to Reddit Submit to Furl Submit to Del.icio.us Submit to Google Submit to Yahoo! This Submit to Technorati Submit to StumbleUpon Submit to Spurl Submit to Netscape  < Submit Thread
 
Thread Tools Display Modes
  #1  
Old 13th March 2009, 04:51 AM
RSSFeedBot RSSFeedBot is offline
I, Robot
 
About:
Join Date: Jul 2008
Posts: 3,062
Join Date: Jul 2008
Marketplace reputation 0% (0)
CPD Points: 1
Thanks: 0
Thanked 5 Times in 5 Posts
Default BioCis Pharma Starts Phase IIa Trial In Psoriasis

Podiatry Arena members do not see these ads
BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical testing of ProtoCure(TM) emulsion cream, the company's novel topical drug for dermatology. The double-blind, vehicle-controlled study is designed to evaluate the tolerability, pharmacokinetics, and efficacy of the topical product in a total of 18 subjects with mild to moderate plaque psoriasis.

More...
Reply With Quote
Sponsored Links
Reply



Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Translate This Page

Similar Threads
Thread Thread Starter Forum Replies Last Post
CPEX Pharmaceuticals Initiates Phase II Clinical Trial Of Nasulin(R) RSSFeedBot Latest Diabetes Medicine Research & News 0 26th February 2009 10:30 AM
Synvista Therapeutics Receives Approval To Begin Phase 2 Trial Of Topical SYI-2074 In Psoriasis RSSFeedBot Latest Dermatology News 0 30th September 2008 02:40 AM
BioCryst Reports Results From BCX-4208 Phase IIa Trial In Subjects With Psoriasis RSSFeedBot Latest Dermatology News 0 5th September 2008 06:01 AM


New To Site? Need Help?

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.


All times are GMT -7. The time now is 03:21 AM.